- Home
- NXTC vs FLYE Comparison
NXTC vs FLYE Comparison
Compare NXTC & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- FLYE
- Stock Information
- Founded
- NXTC 2015
- FLYE 2018
- Country
- NXTC United States
- FLYE United States
- Employees
- NXTC N/A
- FLYE N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- FLYE Aerospace
- Sector
- NXTC Health Care
- FLYE Industrials
- Exchange
- NXTC Nasdaq
- FLYE Nasdaq
- Market Cap
- NXTC 9.3M
- FLYE 10.2M
- IPO Year
- NXTC 2019
- FLYE 2024
- Fundamental
- Price
- NXTC $0.41
- FLYE $0.52
- Analyst Decision
- NXTC Strong Buy
- FLYE
- Analyst Count
- NXTC 2
- FLYE 0
- Target Price
- NXTC $3.50
- FLYE N/A
- AVG Volume (30 Days)
- NXTC 178.3K
- FLYE 117.4K
- Earning Date
- NXTC 05-01-2025
- FLYE 05-23-2025
- Dividend Yield
- NXTC N/A
- FLYE N/A
- EPS Growth
- NXTC N/A
- FLYE N/A
- EPS
- NXTC N/A
- FLYE N/A
- Revenue
- NXTC N/A
- FLYE $28,547,111.00
- Revenue This Year
- NXTC N/A
- FLYE N/A
- Revenue Next Year
- NXTC N/A
- FLYE N/A
- P/E Ratio
- NXTC N/A
- FLYE N/A
- Revenue Growth
- NXTC N/A
- FLYE N/A
- 52 Week Low
- NXTC $0.22
- FLYE $0.33
- 52 Week High
- NXTC $1.82
- FLYE $7.62
- Technical
- Relative Strength Index (RSI)
- NXTC 45.41
- FLYE N/A
- Support Level
- NXTC $0.34
- FLYE N/A
- Resistance Level
- NXTC $0.47
- FLYE N/A
- Average True Range (ATR)
- NXTC 0.06
- FLYE 0.00
- MACD
- NXTC 0.01
- FLYE 0.00
- Stochastic Oscillator
- NXTC 39.66
- FLYE 0.00
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About FLYE Fly-E Group Inc. Common Stock
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.